Shares of Novo Nordisk rose more than 8% on Friday after early prescription data showed an encouraging start to the U.S. launch of the company's new GLP-1 pill for obesity.
In a Friday note, TD Cowe… [+2643 chars]
Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch - CNBC
The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly this year in the obesity drug space.
By:Annika Kim Constantino
Source:CNBC
Published:
Related News
Trump Tariff Threats Weigh on Asian Risk Appetite: Markets Wrap - Bloomberg.com
European and US stock futures fell and haven assets such as gold rallied after President Donald Trump proposed new levies on eight countries that have opposed his plans to acquire Greenland. The dollar weakened against most of its major peers.
Bloomberg•Anand Krishnamoorthy
Trump Tariff Threat to Weigh on Risk Sentiment, European Stocks - Bloomberg.com
US President Donald Trump’s announcement of new tariffs on eight European countries over Greenland weighed on risk sentiment as trading kicked off Monday.
Bloomberg•Farah Elbahrawy, Julien Ponthus
Sequoia to invest in Anthropic, breaking VC taboo on backing rivals: FT - TechCrunch
Sequoia Capital is reportedly joining a blockbuster funding round for Anthropic, the AI startup behind Claude, according to the Financial Times. It's a
TechCrunch•Connie Loizos